Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Ascendis Pharma logo

Ascendis Pharma

Recent Finacing

Series D

Recent Raise

$60M

Ascendis Pharma is a biotechnology company with offices in Denmark, California, and Germany developing TransCon long‑acting prodrug therapeutics, including once‑weekly growth hormone and Treprostinil, with clinical development and manufacturing.

Founded 2006
California, United States
501-1K
Publicly Traded
ascendispharma.com

Highlights

Focus Areas

Biotechnology
Clinical Trials
Health Care

Recent Investors

Venrock logo
Vivo Capital logo
Rock Springs Capital logo
Janus Henderson Investors logo
Sofinnova Partners logo
Sofinnova Ventures logo
OrbiMed logo
RA Capital Management logo
Sectoral Asset Management logo

Financials

$60M

Total Raised

1

Funding round

9

Investors


Team

Upgrade to view the team

See the team members at Ascendis Pharma.